[go: up one dir, main page]

BR0210650A - Tablete, e, uso do mesmo - Google Patents

Tablete, e, uso do mesmo

Info

Publication number
BR0210650A
BR0210650A BR0210650-7A BR0210650A BR0210650A BR 0210650 A BR0210650 A BR 0210650A BR 0210650 A BR0210650 A BR 0210650A BR 0210650 A BR0210650 A BR 0210650A
Authority
BR
Brazil
Prior art keywords
tablet
relates
combinations
methods
present
Prior art date
Application number
BR0210650-7A
Other languages
English (en)
Inventor
Domenico Fanara
Anthony Guichaux
Monique Berwaer
Michel Deleers
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of BR0210650A publication Critical patent/BR0210650A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"TABLETE, E, USO DO MESMO". A presente invenção diz respeito a um tablete que compreende dois segmentos distintos. De um modo mais particular, a invenção está relacionada a combinações de duas substâncias farmacêuticas e a métodos para tratamento de distúrbios alérgicas.
BR0210650-7A 2001-06-28 2002-06-10 Tablete, e, uso do mesmo BR0210650A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30125001P 2001-06-28 2001-06-28
EP01115807 2001-06-28
PCT/EP2002/006342 WO2003002098A1 (en) 2001-06-28 2002-06-10 Tablet comprising cetirizine and pseudoephedrine

Publications (1)

Publication Number Publication Date
BR0210650A true BR0210650A (pt) 2004-10-05

Family

ID=56290291

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0210650-7A BR0210650A (pt) 2001-06-28 2002-06-10 Tablete, e, uso do mesmo

Country Status (22)

Country Link
EP (1) EP1404304B1 (pt)
JP (1) JP4041460B2 (pt)
KR (1) KR100926410B1 (pt)
CN (1) CN100490809C (pt)
AT (1) ATE432068T1 (pt)
AU (1) AU2002345024B2 (pt)
BR (1) BR0210650A (pt)
CA (1) CA2451519C (pt)
CZ (1) CZ20033454A3 (pt)
DK (1) DK1404304T3 (pt)
EE (1) EE05357B1 (pt)
ES (1) ES2324769T3 (pt)
HU (1) HU229803B1 (pt)
MX (1) MXPA03010430A (pt)
NZ (1) NZ530289A (pt)
PL (1) PL206069B1 (pt)
PT (1) PT1404304E (pt)
RO (1) RO122476B1 (pt)
RU (1) RU2286784C2 (pt)
SI (1) SI1404304T1 (pt)
SK (1) SK287645B6 (pt)
WO (1) WO2003002098A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014867B2 (en) * 2001-06-28 2006-03-21 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
WO2007141743A2 (en) * 2006-06-06 2007-12-13 Ranbaxy Laboratories Limited A tablet dosage form comprising cetirizine and pseudoephedrine
KR20090101362A (ko) 2006-12-26 2009-09-25 파마시클릭스, 인코포레이티드 병용 치료에 있어서 히스톤 디아세틸라제 억제제 이용 및 생체표지 감시 방법
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
KR101193495B1 (ko) 2010-02-01 2012-10-23 한미사이언스 주식회사 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
EP2799071B1 (en) 2010-06-16 2018-10-17 Inflammatory Response Research, Inc. Levocetirizine and montelukast for the treatment of influenza and common cold
CN102302497A (zh) * 2011-05-18 2012-01-04 天圣制药集团股份有限公司 一种治疗过敏性鼻炎的制剂及其制备方法
KR20130009553A (ko) 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
ES2627820T3 (es) 2011-09-13 2017-07-31 Pharmacyclics, Inc. Formulaciones de inhibidor de histona desacetilasa en combinación con bendamustina y usos de las mismas
KR101372324B1 (ko) * 2012-02-09 2014-03-13 동국대학교 경주캠퍼스 산학협력단 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물
JP6441888B2 (ja) 2013-03-13 2018-12-19 インフラマトリー・レスポンス・リサーチ・インコーポレイテッド 自己免疫性障害の処置におけるレボセチリジン及びモンテルカストの使用
RU2672871C2 (ru) 2013-03-13 2018-11-20 Инфламматори Респонс Ресёрч, Инк. Применение левоцетиризина и монтелукаста при лечении травматических повреждений
KR20160125283A (ko) 2013-03-13 2016-10-31 인플래머토리 리스폰스 리서치, 아이엔씨. 레보세티리진 및 몬테루카스트의 혈관염의 치료 용도
EP3193875B1 (en) 2014-09-15 2022-02-16 Inflammatory Response Research, Inc. Levocetirizine and montelukast in the treatment of inflammation mediated conditions
WO2016140630A1 (en) 2015-03-05 2016-09-09 PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. An effervescent composition comprising levocetirizine and pseudoephedrine
EP4099977A1 (en) * 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

Also Published As

Publication number Publication date
JP2004536829A (ja) 2004-12-09
HUP0400386A3 (en) 2006-02-28
NZ530289A (en) 2004-11-26
EE200400005A (et) 2004-02-16
CA2451519A1 (en) 2003-01-09
HUP0400386A2 (hu) 2004-08-30
PL206069B1 (pl) 2010-06-30
RO122476B1 (ro) 2009-07-30
EP1404304B1 (en) 2009-05-27
RU2286784C2 (ru) 2006-11-10
WO2003002098A1 (en) 2003-01-09
SK287645B6 (sk) 2011-05-06
MXPA03010430A (es) 2004-12-06
KR20040007756A (ko) 2004-01-24
JP4041460B2 (ja) 2008-01-30
DK1404304T3 (da) 2009-07-13
PL366800A1 (en) 2005-02-07
CN1520285A (zh) 2004-08-11
KR100926410B1 (ko) 2009-11-12
EE05357B1 (et) 2010-12-15
CA2451519C (en) 2007-11-06
SK15502003A3 (sk) 2004-05-04
ATE432068T1 (de) 2009-06-15
HU229803B1 (en) 2014-07-28
PT1404304E (pt) 2009-06-26
CZ20033454A3 (cs) 2004-08-18
ES2324769T3 (es) 2009-08-14
SI1404304T1 (sl) 2009-10-31
CN100490809C (zh) 2009-05-27
AU2002345024B2 (en) 2006-09-07
EP1404304A1 (en) 2004-04-07
RU2004101231A (ru) 2005-04-20

Similar Documents

Publication Publication Date Title
BR0210650A (pt) Tablete, e, uso do mesmo
PT1339399E (pt) Combinacoes de drogas (e.g., clorpromazina e pentamidina) para o tratamento de desordens neoplasicas
BRPI0410503B8 (pt) composição tópica e uso da composição
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
DE602004032522D1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
BR0209812A (pt) Uso de osteopontina para o tratamento e/ou a prevenção de doenças neurológicas
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
ECSP034518A (es) Nuevos retinoides para el tratamiento de enfisema
BRPI0408863A (pt) composto, composição farmacêutica, método para tratar doenças, e, uso de um composto.
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
BRPI0718469A2 (pt) Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto.
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
BRPI0607684A2 (pt) composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
EA200500774A1 (ru) Новая синергетическая комбинация, включающая рофлумиласт и формотерол
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
DE60322577D1 (de) Tablette enthaltend efletirizin und pseudoephedrin

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 31/137, A61K 31/495, A61K 47/36, A61P 47/38, A61K 9/20, A61K 9/24, A61K 9/26, A61P 11/00, A61P 11/02, A61P 27/02, A61P 37/08

Ipc: A61K 9/20 (2011.01), A61K 31/495 (2011.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.